
Purespring Therapeutics
Developer of kidney-targeted gene therapy products intended for the treatment of chronic glomerular kidney diseases, including rare inherited and non-genetic conditions. The company offers a podocyte-...
Valuation
$81.6M
Latest known
Share Price
N/A
Total Raised
$164.7M
Last Round
N/A